The Amateur Traders Corner Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ashley800 who wrote (18156)	1/9/2002 3:02:55 PM
From: Tom Hua	Read Replies (1) of 19633

Wednesday January 9, 1:51 pm Eastern Time BioReliance sees 1st qtr net below 4th qtr ROCKVILLE, Md., Jan 9 (Reuters) - BioReliance Corp., which conducts clinical trials for drug companies, on Wednesday reaffirmed earnings projections for the fourth quarter and full-year 2001, and said first-quarter 2002 profits would be hurt by employee salary increases and higher tax rates. BioReliance (NasdaqNM:BREL - news) expects to earn between 15 cents and 19 cents per share for the first quarter of 2002, lower than estimated fourth-quarter earnings of 21 cents to 26 cents per share. The company expects full-year 2002 profits of 90 cents to $1 per share, up from projected 2001 EPS of 62 cents to 67 cents, which the company reaffirmed on Wednesday. BioReliance expects the number of shares outstanding in 2002 to be grea

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next